AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea · Delayed Price · Currency is KRW 8,290.00
+20.00 (0.24%)
Sep 19, 2025, 3:30 PM KST
AptaBio Therapeutics Revenue
AptaBio Therapeutics had revenue of 1.12B KRW in the quarter ending June 30, 2025, with 0.18% growth. This brings the company's revenue in the last twelve months to 3.11B, up 51.25% year-over-year. In the year 2024, AptaBio Therapeutics had annual revenue of 3.36B with 937.76% growth.
Revenue (ttm)
3.11B
Revenue Growth
+51.25%
P/S Ratio
74.46
Revenue / Employee
75.82M
Employees
41
Market Cap
231.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.36B | 3.04B | 937.76% |
| Dec 31, 2023 | 323.87M | 275.52M | 569.80% |
| Dec 31, 2022 | 48.35M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition